• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

数十年历程:局部晚期直肠癌治疗与共同决策的演变

Journey through the Decades: The Evolution in Treatment and Shared Decision Making for Locally Advanced Rectal Cancer.

作者信息

Gaetani Racquel S, Ladin Keren, Abelson Jonathan S

机构信息

Department of Colon and Rectal Surgery, Lahey Hospital and Medical Center, Burlington, MA 01805, USA.

Department of Community Health, Tufts University, Medford, MA 02155, USA.

出版信息

Cancers (Basel). 2024 Aug 9;16(16):2807. doi: 10.3390/cancers16162807.

DOI:10.3390/cancers16162807
PMID:39199579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11353159/
Abstract

The management of locally advanced rectal cancer has undergone significant transformations over the decades and optimal treatment approaches continue to evolve. There have been numerous advances in surgery, chemotherapy, and radiation therapy from the first description of the abdominoperineal resection in 1908, timing of chemotherapy and radiation therapy in the late 20th and early 21st century, and most recently, the introduction of organ preservation or nonoperative management in 2004. Alongside these advancements, the concept of shared decision making in medicine has evolved, prompting a focus on patient-centered care. This evolution in practice has been fueled by a growing recognition of the importance of patient autonomy and the alignment of treatment options with patients' values and preferences. With the growing number of possible treatment options, variability in patient counseling exists, highlighting the need for a standardized approach to shared decision making in locally advanced rectal cancer. This narrative review will describe the evolution of treatment options of locally advanced rectal cancer as well as the concept of shared decision making and decision aids, and will introduce a decision aid for patients with locally advanced rectal cancer who have achieved a complete clinical response and are eligible for watch and wait.

摘要

几十年来,局部晚期直肠癌的管理发生了重大变革,最佳治疗方法也在不断发展。自1908年首次描述腹会阴联合切除术以来,手术、化疗和放疗取得了诸多进展,20世纪末和21世纪初化疗和放疗的时机得到确定,最近在2004年引入了器官保留或非手术治疗。伴随着这些进展,医学中共同决策的概念也在演变,促使人们关注以患者为中心的护理。这种实践中的演变源于对患者自主权重要性的日益认识以及治疗选择与患者价值观和偏好的契合。随着可能的治疗选择数量不断增加,患者咨询存在差异,这凸显了在局部晚期直肠癌中采用标准化共同决策方法的必要性。这篇叙述性综述将描述局部晚期直肠癌治疗选择的演变以及共同决策和决策辅助工具的概念,并将为已获得完全临床缓解且符合观察等待条件的局部晚期直肠癌患者引入一种决策辅助工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c31/11353159/1d769093a76d/cancers-16-02807-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c31/11353159/1d769093a76d/cancers-16-02807-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c31/11353159/1d769093a76d/cancers-16-02807-g001.jpg

相似文献

1
Journey through the Decades: The Evolution in Treatment and Shared Decision Making for Locally Advanced Rectal Cancer.数十年历程:局部晚期直肠癌治疗与共同决策的演变
Cancers (Basel). 2024 Aug 9;16(16):2807. doi: 10.3390/cancers16162807.
2
A contemporary assessment of total neoadjuvant therapy (TNT) protocols for locally advanced rectal cancer: adoption and expert perspectives at German Cancer Society (DKG)-certified colorectal cancer centers.当代局部晚期直肠癌新辅助治疗(TNT)方案评估:德国癌症协会(DKG)认证结直肠肿瘤中心的采用情况和专家观点。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12591-12596. doi: 10.1007/s00432-023-05139-6. Epub 2023 Jul 12.
3
Personalized medicine for locally advanced rectal cancer: five years of complete clinical response after neoadjuvant radiochemotherapy-a case report with a literature review.局部晚期直肠癌的个性化医疗:新辅助放化疗后五年完全临床缓解——一例病例报告并文献复习
Front Surg. 2024 Mar 25;11:1385378. doi: 10.3389/fsurg.2024.1385378. eCollection 2024.
4
A practical review of watch-and-wait approach in rectal cancer.直肠癌观察等待疗法的实践综述
Radiat Oncol J. 2023 Mar;41(1):4-11. doi: 10.3857/roj.2023.00038. Epub 2023 Mar 28.
5
A Qualitative Exploration of Stakeholders' Preferences for Early-Stage Rectal Cancer Treatment.利益相关者对早期直肠癌治疗偏好的定性探索
Ann Surg Open. 2023 Dec 14;4(4):e364. doi: 10.1097/AS9.0000000000000364. eCollection 2023 Dec.
6
A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management.一种动态临床计算器,用于估算直肠癌全新辅助治疗后行手术或观察等待管理的条件无复发生存率。
JAMA Netw Open. 2022 Sep 1;5(9):e2233859. doi: 10.1001/jamanetworkopen.2022.33859.
7
Nonoperative Management Versus Radical Surgery of Rectal Cancer After Neoadjuvant Therapy-Induced Clinical Complete Response: A Markov Decision Analysis.新辅助治疗诱导临床完全缓解后直肠癌的非手术治疗与根治性手术:一项马尔可夫决策分析。
Dis Colon Rectum. 2020 Aug;63(8):1080-1089. doi: 10.1097/DCR.0000000000001665.
8
ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer.联盟A022104/NRG-GI010:杰纳斯直肠癌试验:一项随机II/III期试验,旨在测试三联化疗与双联化疗在局部晚期直肠癌患者的临床完全缓解率和无病生存率方面的疗效。
medRxiv. 2024 Apr 27:2024.04.25.24306396. doi: 10.1101/2024.04.25.24306396.
9
[Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].巩固性新辅助治疗或全新辅助治疗后低位直肠癌的保直肠手术:初步报告
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):281-288. doi: 10.3760/cma.j.cn.441530-20200228-00096.
10
Advances in the treatment of locally advanced rectal cancer.局部晚期直肠癌的治疗进展
Ann Gastroenterol Surg. 2020 Aug 30;5(1):32-38. doi: 10.1002/ags3.12389. eCollection 2021 Jan.

引用本文的文献

1
Personalized Treatment Modalities for Rectal Cancer: Advances in Neoadjuvant Treatment.直肠癌的个性化治疗模式:新辅助治疗的进展
J Clin Med. 2025 Jun 20;14(13):4411. doi: 10.3390/jcm14134411.
2
Shared Decision Making in the Treatment of Rectal Cancer.直肠癌治疗中的共同决策
J Clin Med. 2025 Mar 26;14(7):2255. doi: 10.3390/jcm14072255.

本文引用的文献

1
Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH).基于免疫治疗的总新辅助治疗在熟练错配修复或微卫星稳定局部晚期直肠癌中的随机 II 期试验(TORCH)。
J Clin Oncol. 2024 Oct;42(28):3308-3318. doi: 10.1200/JCO.23.02261. Epub 2024 Jul 1.
2
Influence of the COVID-19 Pandemic on Patients with Rectal Cancer.新冠疫情对直肠癌患者的影响。
J Clin Med. 2024 Jun 18;13(12):3568. doi: 10.3390/jcm13123568.
3
Patient control preferences for medical decision making before and after evaluation for left ventricular assist device.
左心室辅助装置评估前后患者对医疗决策的控制偏好
Am Heart J Plus. 2023 Jan 3;26:100245. doi: 10.1016/j.ahjo.2022.100245. eCollection 2023 Feb.
4
Efficacy and safety of PD-1 blockade plus long-course chemoradiotherapy in locally advanced rectal cancer (NECTAR): a multi-center phase 2 study.PD-1阻断联合长疗程放化疗治疗局部晚期直肠癌的疗效和安全性(NECTAR):一项多中心2期研究
Signal Transduct Target Ther. 2024 Mar 11;9(1):56. doi: 10.1038/s41392-024-01762-y.
5
Total Neoadjuvant Therapy With PD-1 Blockade for High-Risk Proficient Mismatch Repair Rectal Cancer.帕博利珠单抗新辅助治疗高风险微卫星稳定型直肠腺癌
JAMA Surg. 2024 May 1;159(5):529-537. doi: 10.1001/jamasurg.2023.7996.
6
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
7
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer 2023 Supplement.美国结肠和直肠外科医师协会《2023年直肠癌管理临床实践指南补充版》
Dis Colon Rectum. 2024 Jan 1;67(1):18-31. doi: 10.1097/DCR.0000000000003057. Epub 2023 Aug 20.
8
Long-term Quality of Life and Functional Outcome of Patients With Rectal Cancer Following a Watch-and-Wait Approach.直肠癌患者“观察等待”策略后的长期生活质量和功能结局。
JAMA Surg. 2023 May 1;158(5):e230146. doi: 10.1001/jamasurg.2023.0146. Epub 2023 May 10.
9
Development of a Patient Decision Aid for Rectal Cancer Patients with Clinical Complete Response after Neo-Adjuvant Treatment.为新辅助治疗后达到临床完全缓解的直肠癌患者开发患者决策辅助工具。
Cancers (Basel). 2023 Jan 28;15(3):806. doi: 10.3390/cancers15030806.
10
Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial.短程放疗联合化疗和手术与长程放化疗和手术的局部区域失败比较:RAPIDO 试验的 5 年随访。
Ann Surg. 2023 Oct 1;278(4):e766-e772. doi: 10.1097/SLA.0000000000005799. Epub 2023 Jan 20.